NCT07216508

Enrolling By Invitation

Liver Transplant CGM

Icahn School of Medicine at Mount Sinai Source

Compare

Other study identifiers

Sponsor study identifier

STUDY-24-01098

Study Type

observational

Estimated enrollment

40

Locations

1 country

Sites

1

Timeline

Study Start

October 13, 2025

Actual (reported)

Primary Completion

November 30, 2026

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Study Completion

December 30, 2027

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Brief Summary

This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: enrolling by invitation
Estimated enrollment: 40 participants
Study completion date: December 30, 2027
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
October 9, 2025
Actual (reported)
Study Start
October 13, 2025
Actual (reported)
First Posted
October 14, 2025
Actual (reported)
Primary Completion
November 30, 2026
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 30, 2027
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.

Last Updated: August 24, 2026
Status Verified: August 2026
Last Update Submitted: August 20, 2026

Conditions

Liver Transplant Post Transplant Diabetes Type 2 Diabetes

Keywords

liver transplanthyperglycemiadiabetescontinuous glucose monitoringglucose sensor

Outcome Measures

Primary Outcomes (1)

Time in range
Time in range 70-180mg/dL
28 days

Secondary Outcomes (5)

Percent time >180mg/dL
28 days
Percent time >250mg/dL
28 days
Percent time <70mg/dL
28 days

Study Arms (1)

Participants post liver transplant

Participants who are discharged from after liver transplant.

Device: Libre 3+

Interventions

Libre 3+Device

Blinded CGM will be worn by all participants

Also known as: blinded CGM

Participants post liver transplant

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL

You may qualify if:

inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL

You may not qualify if:

Sponsors & Collaborators

Icahn School of Medicine at Mount Sinai
Otherlead

Study Sites (1)

Mount Sinai Hospital

New York, New York, 10029, United States

MeSH Terms

Conditions

Diabetes Mellitus, Type 2HyperglycemiaDiabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

Grenye O'Malley, MD
Icahn School of Medicine at Mount Sinai
PRINCIPAL INVESTIGATOR

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Associate Professor

Study Record Dates

First Submitted

October 9, 2025

First Posted

October 14, 2025

Study Start

October 13, 2025

Actual (reported)

Primary Completion

November 30, 2026

Estimated

NCT07890818

Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring

Not ApplicableNot Yet Recruiting

NCT06601166

CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin

Not ApplicableActive Not Recruiting

NCT06516640

Type 2 Continuous Glucose Monitoring Academy

Not ApplicableRecruiting

NCT06868589

Reducing Pain With Methadone and Ketamine in Liver Transplant

Phase 4Completed

NCT07587151

Remote Pharmacy Services Plus Continuous Glucose Monitoring in an Underserved Population

Not ApplicableCompleted

NCT06816303

Patients With Diabetes Mellitus on Drug Treatment on the List or Already Undergoing Orthotopic Liver Transplantation

Recruiting

Percent time <54mg/dL

28 days

Transplant outcomes

1 year

having a planned discharge to a rehabilitation or nursing facility,
a contraindication to sensor placement,
if discharge is anticipated to be \>30 days post-transplant, or
if recent transplant also included a kidney or pancreas transplant

Contact the study team to confirm eligibility.

Planned date reported by the registry; this milestone is not confirmed as achieved.

Study Completion

December 30, 2027

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Last Updated

August 24, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT07216508
Data provider: ClinicalTrials.gov
Source updated: 2026-08-24
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:32:58 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (5)

Study Arms (1)

Participants post liver transplant

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

Data Sharing

Source record

Locations